Indo Rama Synthetics (India) Limited
Valuation (92/100) does the heavy lifting; quality (41/100) is the drag.
Buy zoneSolvency riskStocksWizard rates Indo Rama Synthetics (India) Limited a Sell, scoring 40/100 on our blended model. At ₹56.25 it trades below our blended DCF and relative-multiples fair value of ₹112.5, about 100% upside to that estimate — we read it as undervalued by 100%. On 8.4x trailing earnings it sits cheaper than the Consumer Cyclical median of about 27.7x. The price is about 24% below its 52-week high of ₹73.88 and 87% above the low of ₹30.09. Financial health scores 0/100, in the distress band on the Altman Z-score, with a Piotroski F-score of 6/9. It clears 6 of 13 investability checks, with durability 41, valuation 83 and momentum 86 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹90. Low-confidence estimate — limited data.
1-year price
EOD · 2026-07-3152-week range
-23.86% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell40Piotroski F-score 6/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Pass: ROE above 15%: 33.9%
- Fail: Low debt (D/E < 0.5): 2.20x
- Fail: Positive free cash flow
- Fail: Revenue growth > 10%: 0%
- Pass: Earnings growing: 26%
- Fail: Net margin ≥ 10%: 3.1%
- Fail: Current ratio > 1.5: 0.75
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Pass: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Fail: Altman Z in safe zone: Z 0.68
- Fail: Piotroski ≥ 7: 6/9
Shareholding
- Promoter87.8%
- Institutions0.0%
- Public & other12.2%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Strong return on equity (33.9%).
Opportunities
- Earnings growing (26% YoY).
- Trading in our value buy zone versus sector peers.
- Trades ~100% below our estimated fair value.
Bear case
Weaknesses
- High debt relative to equity.
Threats
- Balance-sheet stress — Altman Z 0.68.
About Indo Rama Synthetics (India) Limited
Indo Rama Synthetics (India) Limited manufactures and trades polyester products across India, Turkey, Nepal, and international markets. Its product portfolio includes polyester staple fiber, partially oriented yarn, polyester filament yarn, draw texturized yarn, fully drawn yarn, and polyester chips. The company also trades spun yarn and operates flake-to-chip conversion processes.
Indo Rama Synthetics (India) Limited — frequently asked questions
Is Indo Rama Synthetics (India) Limited a buy, hold or sell?
StocksWizard currently rates Indo Rama Synthetics (India) Limited (INDORAMA) a Sell, based on a blended score of 40/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Indo Rama Synthetics (India) Limited's fair value?
Our blended DCF and relative-valuation model estimates Indo Rama Synthetics (India) Limited's fair value at about ₹112.5, versus a current price of ₹56.25 — roughly 100% upside. On that basis the stock looks undervalued by 100%.
Is Indo Rama Synthetics (India) Limited financially healthy?
Indo Rama Synthetics (India) Limited scores 0/100 on our financial-health model, placing it in the distress band on the Altman Z-score, with a Piotroski F-score of 6/9.
How has Indo Rama Synthetics (India) Limited's share price performed?
Indo Rama Synthetics (India) Limited is up 48% over three months, and last traded at ₹56.25. Past performance doesn't predict future returns.
More in Consumer Cyclical
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.